NCT01075087

Brief Summary

The use of preoperative TAP block in laparoscopic bariatric surgery can improve the postoperative pain and quality of recovery in patients undergoing these procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 24, 2010

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

June 26, 2014

Completed
Last Updated

June 26, 2014

Status Verified

May 1, 2014

Enrollment Period

2.3 years

First QC Date

February 23, 2010

Results QC Date

May 23, 2014

Last Update Submit

May 23, 2014

Conditions

Keywords

TAP BlockPainObesitySurgeryLaparoscopic Banding

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery 40 Score

    Quality of Recovery 40 Score at 24 hours postoperative.

    24 hours post operatively

Secondary Outcomes (1)

  • 24 Hour Total Opioid Consumption.

    24 hours

Study Arms (2)

Placebo

PLACEBO COMPARATOR

(control group) will receive sterile normal saline in the block

Drug: Placebo

Active comparator

ACTIVE COMPARATOR

(study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side.

Drug: (study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side.

Interventions

Bilateral TAP block using sterile normal saline.

Placebo

(study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side.

Active comparator

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-65 years
  • BMI \>35 Kg/m2
  • Surgery: laparoscopic gastric bypass surgery
  • ASA status: I, II and III
  • Fluent in English

You may not qualify if:

  • History of allergy to local anesthetics
  • Chronic opioid use
  • Pregnant patients
  • Patients who remained intubated after surgery
  • Drop-out criteria:
  • Patient or surgeon request Complications related to the procedure or conversion to open route Patient requiring mechanical ventilation after surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location

Related Publications (11)

  • Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology. 2001 Feb;120(3):669-81. doi: 10.1053/gast.2001.22430.

    PMID: 11179243BACKGROUND
  • Peiser J, Lavie P, Ovnat A, Charuzi I. Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery. Ann Surg. 1984 Jan;199(1):112-5. doi: 10.1097/00000658-198401000-00020.

    PMID: 6691724BACKGROUND
  • Kyzer S, Charuzi I. Obstructive sleep apnea in the obese. World J Surg. 1998 Sep;22(9):998-1001. doi: 10.1007/s002689900506.

    PMID: 9717428BACKGROUND
  • Rosenberg-Adamsen S, Kehlet H, Dodds C, Rosenberg J. Postoperative sleep disturbances: mechanisms and clinical implications. Br J Anaesth. 1996 Apr;76(4):552-9. doi: 10.1093/bja/76.4.552. No abstract available.

    PMID: 8652329BACKGROUND
  • Alexander CM, Gross JB. Sedative doses of midazolam depress hypoxic ventilatory responses in humans. Anesth Analg. 1988 Apr;67(4):377-82.

    PMID: 3354874BACKGROUND
  • Dhonneur G, Combes X, Leroux B, Duvaldestin P. Postoperative obstructive apnea. Anesth Analg. 1999 Sep;89(3):762-7. doi: 10.1097/00000539-199909000-00045.

    PMID: 10475322BACKGROUND
  • Chung F, Crago RR. Sleep apnoea syndrome and anaesthesia. Can Anaesth Soc J. 1982 Sep;29(5):439-45. doi: 10.1007/BF03009406.

    PMID: 6751498BACKGROUND
  • Passannante AN, Tielborg M. Anesthetic management of patients with obesity with and without sleep apnea. Clin Chest Med. 2009 Sep;30(3):569-79, x. doi: 10.1016/j.ccm.2009.05.009.

    PMID: 19700053BACKGROUND
  • Wills VL, Hunt DR. Pain after laparoscopic cholecystectomy. Br J Surg. 2000 Mar;87(3):273-84. doi: 10.1046/j.1365-2168.2000.01374.x.

    PMID: 10718794BACKGROUND
  • Goldstein A, Grimault P, Henique A, Keller M, Fortin A, Darai E. Preventing postoperative pain by local anesthetic instillation after laparoscopic gynecologic surgery: a placebo-controlled comparison of bupivacaine and ropivacaine. Anesth Analg. 2000 Aug;91(2):403-7. doi: 10.1097/00000539-200008000-00032.

    PMID: 10910857BACKGROUND
  • Shaw IC, Stevens J, Krishnamurthy S. The influence of intraperitoneal bupivacaine on pain following major laparoscopic gynaecological procedures. Anaesthesia. 2001 Nov;56(11):1041-4. doi: 10.1046/j.1365-2044.2001.02215.x.

    PMID: 11703235BACKGROUND

MeSH Terms

Conditions

PainObesity

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody Weight

Results Point of Contact

Title
Gildasio De Oliveira MD,MS
Organization
Northwestern University

Study Officials

  • Gildasio DeOliveira, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 23, 2010

First Posted

February 24, 2010

Study Start

March 1, 2010

Primary Completion

July 1, 2012

Study Completion

August 1, 2012

Last Updated

June 26, 2014

Results First Posted

June 26, 2014

Record last verified: 2014-05

Locations